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Introduction: Ocular trauma is defined as a trauma caused by blunt or penetrating mechanisms on the eyeball
and its peripheral structures, causing damage with different degrees of affection with temporary or permanent
visual function compromise. Ocular trauma is a major cause of preventable blindness worldwide; it constitutes 7%
of all corporal injury and 10% to 15% of all eye diseases. Regenerative medicine research has opened up the
possibility to use stem cells as a source of cell replacement, so that experimental studies on embryonic stem cells
and bone marrow stem cells have been carried out. In this study, we analyzed the histopathological and
spectroscopic changes in ocular tissue with trauma, treated with mouse pluripotent stem cells.
Methods: Firstly, mouse embryonic stem cells were seeded. Subsequently, the obtained cells were implanted in a
murine model of scleral and retinal damage at the first, second, and fourth weeks post-trauma. At week 12 post-trauma,
the eyes were enucleated for histopathologic study (inflammatory response and histological integrity) and spectroscopic
analysis by Fourier transform infrared spectroscopy in the attenuated total reflection configuration. Data were analyzed
by one-way analysis of variance.
Results: Histopathological results showed that the experimental groups treated with stem cells presented a decrease in
the inflammatory response, and the histological integrity was restored, which contrasted with the experimental group
treated with saline solution. Moreover, in the spectroscopic analysis, characteristic bands of biological samples were
observed in all tissues, highlighting in healthy tissues the presence of C = O bond at 1,745 cm-1, which was not
observed in the injured and treated tissues. Also, the absorption spectrum of the tissues treated with embryonic stem
cells showed bands whose intensity was high at around 1,080 to 1,070 cm-1. It has been reported that these bands are
characteristic of pluripotent stem cells.
Conclusions: The implant of embryonic stem cells could be a useful therapeutic treatment after traumatic eye injuries
or many other eye diseases to reduce the inflammatory response and restore histological integrity. Furthermore, the
spectroscopic technique could be used as a complementary technique for detecting stem cell incorporation into
various tissues.* Correspondence: mmcmaribel@gmail.com
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“Ocular trauma” (OT) is defined as trauma caused by
blunt or penetrating mechanisms on the eyeball and its
peripheral structures, causing tissue damage with differ-
ent degrees of affection with temporary or permanent
visual function compromise [1]. This is a worldwide
cause of visual morbidity and is a leading cause of non-
congenital monocular blindness in children [2].
OT is a major cause of preventable blindness worldwide;
it constitutes 7% of all corporal injury and 10% to 15% of
all eye diseases. It has become the most frequent cause of
hospitalization of ophthalmological patients [3]; in the US,
the incidence is almost 2.5 million per year [4].
World Health Organization estimates, in its prevention
of accidents program, that there are 55 million eye injuries
annually, of which 200,000 are open globe injuries [1]. It is
reported that worldwide 1.6 million people are blind as a
result of ocular injuries, 2.3 million with low visual acuity
bilaterally, and 19 million with low vision or monocular
blindness [5].
An open OT should be urgently operated [1]. Closure
of OT wounds by penetration must restore the anatomy
and functional architecture [6].
Owing to surgical complications, different ways to re-
store retinal degeneration through some type of transplant
have been thought, but, in contrast to solid organ trans-
plants, which only require re-anastomosis of large vessels
and ducts, the transplantation of a whole eye would require
the restoration of more than a million axonal connections
between the inner retina and the lateral geniculate nucleus
of thalamus, located several centimeters away [7].
Current medical research has focused mainly on devel-
oping therapeutic strategies for neuroprotection and cell
replacement. Cell replacement is a novel therapeutic ap-
proach to restore visual capabilities on degenerated retinal
illness and represents an emerging field of regenerative
neurotherapy. Since the discovery of stem cells (SCs),
these have been used as a source of cell replacement, so
that experimental studies on neural SCs, embryonic SCs
(ESCs), and bone marrow SCs are carried out. These stud-
ies try to confirm the potential of SC transplantation and
the integration in the retina after the transplantation, lead-
ing to appropriate visual processing [8,9].
An SC is defined as a cell capable of dividing indefinitely
and differentiating into several specialized cell types, not
only morphologically but also functionally. According to
their origin and developmental potential, SCs are classified
as totipotent, pluripotent, multipotent, and unipotent.
With this, we can mention two important SC applications:
first, their differentiation potential would allow us to use
them to regenerate damaged or destroyed tissue; second,
the SCs may be used as a gene therapy vehicle in the case
of monogenic diseases such as hemophilia or even as
an antitumor vehicle or antiangiogenic therapies [7]. ForSC therapies, the retina has the optimal combination of
ease of surgical access and an ability to observe trans-
planted cells directly through the clear ocular media [10].
ESCs have been used in retinal vascular disease, Star-
gardt disease, retinitis pigmentosa, macular degeneration,
and photoreceptor dystrophy with different methods
[10-12]. Furthermore, two clinical trials for SC-based
therapies in retinal diseases have been approved by the
US Food and Drug Administration and initiated by Ad-
vanced Cell Technology (Santa Monica, CA, USA), which
plans to include patients with Stargardt disease and geo-
graphic atrophy secondary to age-related macular degen-
eration (AMD) [12].
Some studies show the absence of side effects from SC
therapy in ocular lesions, such as hyperproliferation,
tumorigenicity, ectopic tissue, or rejection, after 4 months
of follow-up [13].
In addition to the OT histopathological studies, the
potential of infrared vibrational spectroscopy in moni-
toring biochemical changes associated with retinal re-
sponse to light incident has been shown [14]. Moreover,
the recent adoption of vibrational spectroscopic ap-
proaches to study SC differentiation has emerged as a
modern technique [15]. One of these modalities, Fourier
transform infrared (FTIR) spectroscopy, has been used
for the recent characterization of pluripotent and multi-
potent SCs [16].
The aim of this study is to determine the ability of
ESCs to restore eye injuries; histopatological and spectro-
scopic studies were performed by FTIR, which allowed
us to determine the capacity to restore eye tissue after
OT.
Materials and methods
Embryonic stem cell culture
The mouse embryonic SCs (mESCs) (ATCC, Manassas,
VA, USA; SCRC-1011) were seeded at a density of 50,000
cells per cm2 on a monolayer of mouse embryonic fibro-
blasts which were previously mitotically inactive for mESC
growing. We used mESC basal medium (ATCC, catalog
number SCRR-2010) supplemented with 15% fetal bovine
serum, 0.1 mM 2-mercaptoethanol (Invitrogen, Carlsbad,
CA, USA; catalog number 21985023), and 1,000 U/mL
mouse leukemia inhibitory factor (Chemicon, now part of
EMD Millipore, Billerica, MA, USA; catalog number
ESG1107). The culture dishes were incubated at 37°C in
a humidified 5% CO2 and 95% air incubator [17]. When
the cultures reached 70% confluency, doses of 20,000
and 50,000 mESCs were obtained and resuspended in
0.025 mL of 0.09% balanced salt solution (BSS).
A murine model of ocular trauma
This experimental work followed the guidelines of the
Norma Oficial Mexicana Guide for the use and care of
Figure 1 Experimental methodology. (A) Experimental groups. To all groups, an ocular trauma (OT) was induced; group 1 received balanced
salt solution (BSS), group 2 had an intravitreal implant of 20,000 mouse embryonic stem cells (mESCs) resuspended in 0.025 mL of BSS, and group
3 was treated with an intravitreal implant of 50,000 mESCs resuspended in 0.025 mL of BSS. (B) Experimental methodology. After OT (day 0) and
at the first, second, and fourth weeks post-trauma, the groups received their experimental treatment according to the group that they belong to;
at 12 weeks post-trauma, rats were sacrificed and the eyes were enucleated for their histopatological and spectroscopy analysis.
Figure 2 Stem cell culture. Mouse embryonic stem cells (400×)
integrating a colony that is under a mouse embryonic
fibroblast monolayer.
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disposal of biological residues (NOM-087-ECOL-1995).
The animals were males of the Rattus norvegicus strain
and were 12 weeks of age. They were kept in metabolic
cages in a temperature-controlled environment with a
12-hour light/dark cycle and were allowed free access to
food and water at all times.
Since there are no reports of mouse models with OT,
this model was standardized by injuring the sclera and
the entire retina. By intraperitoneal injection, anesthesia
with ketamine (50 mg/kg) and xylazine (8 mg/kg) was
administered by using asepsis and antisepsis protocols
with 10% povidone-iodine solution. OT was performed
by scleral puncture by the pars planar with a 27G trocar,
reaching the retina and causing a lesion of 1 mm in
length in the temporary area outside the vascular ar-
cades in order to avoid vascular damage and to obtain a
suitable visual field for the realization of the lesion. The
total thickness of the retinotomy spanned the internal
limiting membrane and the photoreceptors layer. These
procedures were performed by an ophthalmologist using
an indirect ophthalmoscope and a 22-diopter lens. All
procedures involving animals were approved by the Ethics
Committee for Animal Research of Escuela Militar de
Graduados de Sanidad.
Implantation of mouse embryonic stem cells (pluripotent)
In this study, 30 male Rattus norvegicus rats were ran-
domly divided into three groups (n =10 right eyes of rat
per group). All members of the groups were subjected to
the OT described above and subsequently received the
intravitreal injections with different treatments according
to the group that they belonged to at the first, second, and
fourth week post-trauma. Group 1 (control group) had in-
travitreal injections of 0.025 mL of BSS, group 2 receivedan intravitreal implant of 20,000 mESCs resuspended in
0.025 mL of BSS, and group 3 had an intravitreal im-
plant of 50,000 mESCs resuspended in 0.025 mL of BSS
(Figure 1).
Histopathological and ATR-FTIR spectroscopy analysis
After 12 weeks of OT and treatment, the animals were
sacrificed and their eyes stored at −40°C; thereafter,
histological sections of 4-μm thickness were obtained by
using a cryostat (Jaelsa, Madrid, Spain). For the histo-
pathological study, the histological sections were imme-
diately fixed in 4% paraformaldehyde and stained with
hematoxylin and eosin in order to be analyzed by a
pathologist using brightfield microscopy (Carl Zeiss,
Jena, Germany; Axioskop 2 plus). An FTIR spectrom-
eter (model Vertex 70; Bruker, Billerica, MA, USA) with
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tional analysis, and each tissue section was placed dir-
ectly onto the surface of the ATR crystal spectrometer.
Results
The mESCs are adherent cells characterized mainly by
their growth in colonies (Figure 2). A typical colony for-
mation was shown 24 hours after seeding, and the cul-
ture reached confluence after 72 hours of culture.
Histology of the ocular trauma in a murine model
Forty-eight hours after OT in the mouse model, we
noted destruction of most of the retinal layers, altering
the normal histological conformation characterized by
dissemination of the retinal neuron nucleuses (Figure 3).
Inflammatory response and histological integrity
Intravitreal applications were carried out at a set time
and were uneventful; rejection, endophthalmitis, or any
other secondary complications such as macroscopic
damage were not observed. The inflammatory response
was graded by using as a criterion the number of lym-
phocytes as follows: nil, mild (<5 cells per field of view),
moderate (≥5 cells per field of view), and severe (≥10
cells per field of view). Furthermore, grades of histo-
logical integrity were established as follows: restored,
mild alteration, moderate alteration, and severe alter-
ation, according to the presence of fibroblastic reaction,
loss of the longitudinal axis of the fibroblasts or fibro-
cytes, and recapilarization. In addition, specifically in
scleral tissue, the arrangement of the collagen fibers and
the displacement of normal tissue structures were ana-
lyzed, whereas in the retina, the architecture and cellu-
larity of retinal neurons were examined. However, it is
important to mention that none of the experimentalFigure 3 Histology of the ocular trauma in a murine model.
Alteration of the normal histological conformation of the retina
characterized by dissemination of the retinal neuron nucleuses
48 hours after ocular trauma (400×).
Figure 4 Scleral inflammatory response and histological
integrity. Scleral tissues (400×). (A) In group 1, moderate
inflammatory response characterized by the presence of
lymphocytes (↑) and loss of the arrangement of the collagen fibers
are shown. (B) In group 2, few lymphocytes (↑) and a slight
alteration in the histological integrity were observed. (C) In group 3,
cells involved in the inflammatory response are not shown, and the
arrangement of the collagen fibers was restored, which means that
the scleral histology was recovered.
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sponse or severe alterations of the histological integrity.
According to the inflammatory response, it is worth to
mention that the density and arrangement of the scleral
collagen fibers avoid the diapedesis of a large number of
typical inflammatory cells. Consequently, the histological
architecture hinders the migration and localization of
inflammatory cells in this region.
Group 1 showed moderate inflammatory response in
the 70% of cases, characterized by the presence of lym-
phocytes that are localized between the scleral collagen
fibers that were displaced after injury (Figure 4A). Sev-
enty percent of group 2 exhibited a mild inflammatory
response, and we observed a few lymphocytes in scleral
tissue (Figure 4B). In 50% of the specimens in group 3,
signs of inflammatory response were not observed
(Figure 4C).
In the results obtained from inflammatory response, a
big difference between group 1 and the groups that re-
ceived mESC intravitreal implant (groups 2 and 3) was
demonstrated. Groups 2 and 3 showed a marked decrease
in inflammatory response. Furthermore, the inflammatory
response observed in group 3 was even lower compared
with group 2 (Figure 5).
In regard to histological integrity, 70% of cases in
group 1 showed a moderate alteration characterized
by an irregular pattern of the collagen fibers in the
scleral tissue, which exhibited distortion and rupture.
Also reactive fibroblasts and fibrocytes were observed, as
well as the decrement of the histological architecture.
These histopathological changes correspond to damage
by mechanical action (Figure 4A). In the same way, in





















Figure 5 Inflammatory response. The inflammatory response was graded
cell infiltrate. None of the experimental groups showed any signs of severe
had a moderate alteration, whereas most members of groups 2 and 3 (gro
inflammatory response (P <0.0001).in a topographic context, characterized by the dissemin-
ation of the nucleuses of the retinal neurons (Figure 6A).
Furthermore, in group 2, histological integrity was re-
stored in 80% of samples; in the scleral tissue, collagen
fibers with a regular pattern are noted and the longitu-
dinal axis is mildly restored (Figure 4B). However, in the
retinal area, a restored architecture is observed in its
topography, and homogenization of the retinal layers is
noted since neuronal nucleuses are clustered in a de-
fined area (Figure 6B).
In regard to group 3, 90% of cases restored their histo-
logic integrity. In the scleral tissue, retrieval on the ar-
rangement of collagen fibers is noted in a homogeneous
way with a regular geometrizacion pattern in space.
Also, a major recapilarization was observed, and fibro-
cytes recovered their normal longitudinal axis with a
very well-defined polarity (Figure 4C). However, in the
retinal zone, the architecture was evidently restored up
to 90% since neuronal cellularity shows a normal appear-
ance (Figure 6C). In joint analysis, it is evident that
groups 2 and 3 had a better histological integrity relative
to group 1. As seen in the inflammatory response, histo-
logical integrity was restored in a higher proportion in
group 3 (Figure 7).
Infrared absorption in histological sections
Infrared absorption measurements of each representative
histological section from each condition (healthy tissue, in-
jury tissue, and injury tissue treated with 50,000 mESCs)
were carried out (Figure 8). The presence of many func-
tional groups, characteristic of biological sample, could be
observed. First, in healthy tissue sample, C =O bonds were





as nil, mild, moderate, and severe according to chronic inflammatory
inflammatory response. Most members of group 1 (control group)
ups that received mouse embryonic stem cells) showed a nil and mild
Figure 6 Retinal histological integrity. Retinal tissues (100×). (A)
In group 1, histological integrity, characterized by dissemination of
neuronal cell nuclei, was not retained. (B) In group 2, restored
architecture is observed with homogenization of the retinal layers.
(C) In group 3, restored architecture with normal neuronal cellularity
is shown.
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and amide II (1,538 cm-1) bands of proteins [15]. Likewise,
in the three histological sections in different conditions,
the methyl and methylene groups from lipids and pro-
teins at 1,454 cm-1 were observed [16]. A weak COO-1absorption band at 1,396 cm-1 originating from the
amino acid side chains could be shown. The P = O
bonds at 1,238 and 1,080 cm-1 in healthy and injured
tissues are attributed to the phosphodiester groups from
phosphorylated molecules and glycogen. Also, the ab-
sorption band appearing at 1,158 cm-1 was associated
with a glycogen CO bond, whereas the bands between
1,080 and 1,070 cm-1 were due to the P = O bond of
phosphorylated molecules and to the C-O bond of the
glycogen [14].
Statistical analysis
The treatments were randomly assigned. For the two
histopathological variables studied (inflammatory response
and histological integrity), an ordinal measurement scale
was used. Data were analyzed by one-way analysis of vari-
ance by using Statistic 8.0. For the two studied variables,
the difference between groups 2 and 3 did not reach stat-
istical significance. However, between group 1 and groups
2 and 3, a statistically significant (P <0.0001) was shown.
Discussion
The use of SCs in ophthalmic diseases currently is a
promising treatment that is in active research, and SCs
have increasingly been employed for experimental stud-
ies. However, clinical trials are scarce. In addition, the
few existing studies are more focused on retinal vascular
diseases such as diabetic retinopathy, degenerative retinop-
athy, and retinal dystrophies (AMD, retinitis pigmentosa,
and Stargardt disease) [18]. Early SC therapy approaches
are based on regeneration of damaged tissues such as the
retinal pigment epithelium and photoreceptors, and the
entire retina replacement with differentiated SCs is a more
ambitious goal.
The aim to use SCs in ophthalmic diseases is to re-
place damaged cells and preserve cell function. There-
fore, this study tried to demonstrate the positive effects
on histological restoration after the treatment with ESCs
in an OT. This kind of trauma affects the scleral and ret-
inal histological integrity, causing decreased vision and
sometimes blindness, which severely affects the patient’s
quality of life, besides being associating with a profound
impact on the economy.
In accordance with our results, we can say that treat-
ment with ESCs may be useful to preserve the scleral
and retinal histology and probably the visual function
after OT.
In our study, there was no histological evidence of neo-
plasia (teratomas) at 11 weeks post mESC implantation.
In contrast, Arnhold et al. [19] and Chaudhry et al. [20]
reported the formation of teratomas at 6 and 8 weeks after
differentiated ESC implantation, respectively. This fact
suggests that the implantation of ESCs in a undifferenti-


























Figure 7 Histological integrity. The histological integrity was graded as restored, mild alteration, moderate alteration, and severe alteration,
according to the presence of fibroblastic reaction, loss of the longitudinal axis of the fibroblasts or fibrocytes, arrangement of the collagen fibers,
displacement of normal tissue structures, and recapilarization. None of the experimental groups showed any signs of severe alterations of
histological integrity. Most members of group 1 (control group) had a moderate alteration, whereas groups 2 and 3 (groups that received mouse
embryonic stem cells) showed a restored histological integrity (P <0.0001).
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immune-mediated organ rejection over 3 months’ follow-
up; these results are similar to those reported by Steven
et al. [13].
Currently, few clinical trials in OT handle pluripotent
cells. However, some researchers are performing clinical
trials in retinal dystrophies. For example, Bainbridge et
al. are implanting human ESCs in doses from 50,000 to
200,000 cells in patients over 18 years old with a retinal























































Figure 8 Infrared absorption spectrum. Fourier transform infrared spect
representative histological sections in three different conditions: healthy tis
embryonic stem cells. a.u., arbitrary units.In this study, we implanted 20,000 and 50,000 cells per
dose in different experimental groups without observing
a statistically significant difference between the two
groups. However, in the group that received doses of
50,000 mESCs, there was not reported a single case with
inflammatory response, and histological integrity was re-
covered in 90% of cases, which would be very clinically
useful. Therefore, this study opens the door to future re-
search to assess effectiveness versus cost-effectiveness by














































roscopy in the attenuated total reflection configuration (ATR-FTIR) of
sue, damaged tissue, and damaged tissue treated with 55,000 mouse
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tion, the presence of bands characteristic of biological
samples was observed, encompassing bindings associated
with lipids, proteins, phosphorylated amino acid com-
pounds, and mainly carbohydrates.
It is worth noting that the tissue section of healthy sam-
ple presented a C =O bond at 1,745 cm-1 corresponding
to esters lipids. These lipids were not observed in samples
of injured and treated tissue, and this was probably due to
cell membrane destruction. In addition, in the spectrum
of the samples treated with mESCs, we detected intense
absorption bands between 1,080 and 1,070 cm-1 related to
carbohydrates as glycogen, but these were mainly phos-
phorylated compounds.
Cao et al. have reported that one of the vibrational
characteristics that distinguish pluripotent SCs with re-
spect to specialized cells is increased intensity of FTIR
related with the presence of phosphorylated compound
(1,080 to 1,070 cm-1) [16]. In this way, the use of this
spectroscopic technique is proposed as an additional
tool for SC detection and its incorporation to injured
ocular tissue.
More randomized controlled clinical trials using SCs
in eye diseases are needed, not only for degenerative and
vascular diseases or dystrophies but also for any eye path-
ology in which the anatomy and function are affected,
such as the OT, in order to establish a safe dose with
greater benefits and to determine whether the use of ESCs
is effective in treating a particular condition.
Conclusions
We have shown in a preliminary way that the mESC im-
plant could be very useful as a therapeutic tool after an
OT or many other ophthalmological diseases since this
therapy reduces the inflammatory response and restores
the histological integrity. However, further studies are
needed to determine other parameters such as preserva-
tion of functionality, localization and biodistribution of
mESCs, therapeutic doses, and long-term follow-up. In
the same way, the capacity of FTIR spectroscopy as a
complementary technique was demonstrated in order to
detect the SC implantation and its incorporation in dif-
ferent tissues.
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